Mild cystic fibrosis mutations in Southern Sweden with special reference to S549I and T338I

Clinical Genetics

Volumn 53, Issue 5, 1998, Pages 383-386

  Schaedel, C ^a   Andersson, A M ^a   Kristoffersson, A C ^a   Kornfalt R ^a   Lannefors, L ^a   Holmberg, L ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cystic fibrosis; Missense mutations; Pancreatic sufficiency; Pulmonary function; S549I; T338I

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENE MUTATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; ONSET AGE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; SWEDEN; VITAL CAPACITY;

EID: 0031776081     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02750.x     Document Type: Article

References (14)

1. Welsh M, Tsui L-C, Boat T, Beaudet A. Cystic fibrosis. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. McGraw-Hill: New York, 1995: 3799-3876.
2. Kerem B-S, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan J, Collins F, Rommens J, Tsui L-C. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci 1990: 87: 8447-8451.
3. Tsui L-C. The cystic fibrosis transmembrane conductance regulator gene. Am J Respir Crit Care Med 1995: 151: 47-53.
4. Kerem B-S, Kerem E. The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet 1996: 4: 65-73.
5. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey M-C, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Ferec X, Estivill X. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995: 332: 1475-1480.
6. Zielenski J, Rozmahel R, Bozon D, Kerem B-S, Grzelczak Z, Riordan J, Rommens J, Tsui L-C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991: 10: 214-228.
7. Kerem B-S, Rommens J, Buchanan J, Markiewicz D, Cox T, Chakravarti A, Buchwald M, Tsui L-C. Identification of the cystic fibrosis gene:genetic analysis. Science 1989: 245: 1073-1080.
8. Schaedel C, Kristoffersson A-C, Kornfält R, Holmberg L. A novel cystic fibrosis mutation, Y109C, in the first transmembrane domain of CFTR. Hum Mol Genet 1994: 3: 1001-1002.
9. Saba L, Leoni G, Meloni A, Faa V, Cao A, Rosatelli M. Two novel mutations in the transmembrane domains of the CFTR gene in subjects of Sardinian descent. Hum Mol Genet 1993: 2: 1739-1740.
10. Leoni G, Pitzalis S, Podda R, Zanda M, Silvetti M, Caocci L, Cao A, Rosatelli M. A specific cystic fibrosis mutation (T338I) associated with the phenotype of isolated hypotonic dehydration. J Pediatr 1995: 127: 281-283.
11. Padoan R, Cremonesi L, Giunta A. Mild CF phenotype associated with T338I missense mutation. J Pediatr 1996: 128: 721-722.
12. Kerem E, Corey M, Kerem B-S, Rommens J, Markiewicz D, Levison H, Tsui L-C, Durie P. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (DF508). N Engl J Med 1990: 323: 1517-1522.
13. Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G, O'Riordan C, Smith A. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990: 63: 827-834.
14. Chu C-S, Trapnell B, Curristin S, Cutting G, Crystal R. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993: 3: 151-156.